Stockreport

Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF On April 2, 2024, the EMA approved Reblozyl as a first-line treatment for anemia in certain patients with MDS. On March 14 of this year, Breyanzi was approved by the [Read more]